Cargando…

The tumor microenvironment in gastrointestinal adenocarcinomas revealed a prognostic and immunotherapeutic biomarker

Accumulated evidence has elucidated that the tumor microenvironment (TME) is great of clinical significance in predicting survival outcomes and therapeutic efficacy. Nonetheless, few studies have investigated the prognostic and immunotherapeutic signature correlated with TME phenotypes in gastrointe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yong, Li, Lu, Chu, Feifei, Zhang, Lei, Zhang, Li, Wu, Huili, Li, Kunkun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831739/ https://www.ncbi.nlm.nih.gov/pubmed/36585927 http://dx.doi.org/10.18632/aging.204463

Ejemplares similares

Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signature
por: Zhang, Pengpeng, et al.
Publicado: (2023)

A prognostic and immunotherapeutic predictive model based on the cell-originated characterization of tumor microenvironment in lung adenocarcinoma
por: Xu, Jiachen, et al.
Publicado: (2023)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Tumor microenvironment characterization in head and neck cancer identifies prognostic and immunotherapeutically relevant gene signatures
por: Huo, Mengqi, et al.
Publicado: (2020)

Tumor Microenvironment Profiling Identifies Prognostic Signatures and Suggests Immunotherapeutic Benefits in Neuroblastoma
por: Feng, Chenzhao, et al.
Publicado: (2022)

Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021)

Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma
por: Feng, Wei, et al.
Publicado: (2023)

The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature
por: Zhou, Sitong, et al.
Publicado: (2021)

Identification and Validation of an m6A-Related LncRNA Signature to Predict Progression-Free Survival in Colorectal Cancer
por: Zhang, Yong, et al.
Publicado: (2022)

Up-Regulation of SH3TC2 Induced by YTHDF1 Predicts Poor Outcome and Facilitates Cell-Cycle Progress in Colorectal Cancer
por: Wu, Huili, et al.
Publicado: (2022)

Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature
por: Bao, Xuanwen, et al.
Publicado: (2019)

Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma
por: Bian, Tingting, et al.
Publicado: (2021)

Multi-omics profiling and digital image analysis reveal the potential prognostic and immunotherapeutic properties of CD93 in stomach adenocarcinoma
por: Wu, Baokang, et al.
Publicado: (2023)

Prognostic value of biomarkers in the tumor microenvironment of pancreatic ductal adenocarcinoma
por: Mishra, Nitish K., et al.
Publicado: (2020)

The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer
por: Xu, Xiao, et al.
Publicado: (2022)

Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker
por: Xu, Lidong, et al.
Publicado: (2023)

Diaphanous-related formin subfamily: Novel prognostic biomarkers and tumor microenvironment regulators for pancreatic adenocarcinoma
por: Zhang, Bixi, et al.
Publicado: (2022)

CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets
por: Liu, Fangteng, et al.
Publicado: (2021)

Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2021)

Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity
por: Liu, Senbo, et al.
Publicado: (2023)

Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma
por: Xu, Zhan-yu, et al.
Publicado: (2020)

Tumor Immune Microenvironment Characterization in Hepatocellular Carcinoma Identifies Four Prognostic and Immunotherapeutically Relevant Subclasses
por: Gao, Xingxing, et al.
Publicado: (2021)

Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2022)

IMPACT: A web server for exploring immunotherapeutic predictive and cancer prognostic biomarkers
por: Liu, Yutao, et al.
Publicado: (2023)

Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
por: Zhang, Simeng, et al.
Publicado: (2021)

Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers
por: Mi, Haoyang, et al.
Publicado: (2022)

New Development of Biomarkers for Gastrointestinal Cancers: From Neoplastic Cells to Tumor Microenvironment
por: Zhang, Jiajia, et al.
Publicado: (2018)

PEX13 is a potential immunotherapeutic indicator and prognostic biomarker for various tumors including PAAD
por: Dong, Penggang, et al.
Publicado: (2023)

Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer
por: Jia, Keren, et al.
Publicado: (2022)

Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
por: Song, Chanyoung, et al.
Publicado: (2019)

Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment
por: Zhang, Tao, et al.
Publicado: (2020)

Bioresponsive and immunotherapeutic nanomaterials to remodel tumor microenvironment for enhanced immune checkpoint blockade
por: Fang, Tianxu, et al.
Publicado: (2023)

Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment
por: Zheng, Run, et al.
Publicado: (2022)

The tumor–stroma ratio and the immune microenvironment improve the prognostic prediction of pancreatic ductal adenocarcinoma
por: Lu, Mei, et al.
Publicado: (2023)

KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker
por: Shen, Xiaoju, et al.
Publicado: (2022)

Immunotherapeutic advances in gastrointestinal malignancies
por: Rao, Devika, et al.
Publicado: (2019)

Interrogation of T Cell–enriched Tumors Reveals Prognostic and Immunotherapeutic Implications of Polyamine Metabolism
por: Harbison, R. Alex, et al.
Publicado: (2022)

Corrigendum: Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment
por: Zhang, Tao, et al.
Publicado: (2020)

Correction: Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer
por: Jia, Keren, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9e01kts91bj1a4nesdp3bal91f